Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Neurocrine Bioscienc (NQ: NBIX ) 123.76 -28.79 (-18.87%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 4,827,722 Open 125.90 Bid (Size) 124.00 (3) Ask (Size) 125.88 (8) Prev. Close 152.55 Today's Range 119.76 - 128.00 52wk Range 103.63 - 157.98 Shares Outstanding 100,900,000 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Nasdaq Down Over 1%; Foot Locker Shares Tumble After Q2 Results Today 12:56 EDT Via Benzinga As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors Today 11:16 EDT Neurocrine Biosciences reports Phase 2 trial results for NBI-1117568 showing significant improvement in schizophrenia symptoms, with an 18.2-point reduction in PANSS scores at a 20 mg dose. Via Benzinga Performance YTD -6.05% -6.05% 1 Month -14.80% -14.80% 3 Month -11.90% -11.90% 6 Month -9.02% -9.02% 1 Year +15.79% +15.79% More News Read More US Stocks Mixed; JM Smucker Slashes Annual Guidance Today 10:00 EDT Via Benzinga Neurocrine Bio Dives As Schizophrenia Trial Results Lags Peers Today 8:17 EDT Via Investor's Business Daily Regulators Expected To Approve Innovative Schizophrenia Treatment From Bristol Myers, Karuna August 27, 2024 Via Benzinga Evaluating Neurocrine Biosciences: Insights From 15 Financial Analysts August 19, 2024 Via Benzinga NASDAQ:NBIX—A High-Growth Stock Gearing Up for Its Next Upward Move. August 19, 2024 Via Chartmill NASDAQ:NBIX is not too expensive for the growth it is showing. August 19, 2024 Via Chartmill Why the quality investor may take a look at NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX). August 22, 2024 Via Chartmill 9 Health Care Stocks Whale Activity In Today's Session August 13, 2024 Via Benzinga New Study Reveals How Classical Music Could Revolutionize Depression Care August 12, 2024 Via PressReach Exposures Product Safety So Much For Expecting The Fed To Stick The Landing August 04, 2024 Via Talk Markets Topics Economy Exposures Interest Rates A Closer Look at 7 Analyst Recommendations For Neurocrine Biosciences August 01, 2024 Via Benzinga NASDAQ:NBIX, a strong growth stock, setting up for a breakout. July 26, 2024 Via Chartmill NASDAQ:NBIX, a growth stock which is not overvalued. July 26, 2024 Via Chartmill Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review August 02, 2024 Via Investor's Business Daily Topics Artificial Intelligence Exposures Artificial Intelligence Should Quality Investors Include NASDAQ:NBIX in Their Portfolio? July 25, 2024 Via Chartmill Cracking The Code: Understanding Analyst Reviews For Neurocrine Biosciences July 10, 2024 Via Benzinga Why NASDAQ:NBIX Is a Promising High-Growth Stock in the Midst of Consolidation. July 05, 2024 Via Chartmill NASDAQ:NBIX is not too expensive for the growth it is showing. July 05, 2024 Via Chartmill Reasonable Growth, Debt Levels, and a High ROIC Make NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) Appealing to Quality Investors. July 04, 2024 Via Chartmill Despite its impressive fundamentals, NASDAQ:NBIX remains undervalued. June 20, 2024 Via Chartmill 7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline June 17, 2024 Via InvestorPlace Is NASDAQ:NBIX on the Verge of a Major Breakout as a Strong Growth Stock? June 14, 2024 Via Chartmill Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans June 14, 2024 Via Investor's Business Daily Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
